Dikmen Y.Terek M.C.Sanhal C.Y.Ergenoglu A.M.YenIel A.O.ZekIoglu O.Özsaran A.2019-10-262019-10-2620131300-02921300-0292https://doi.org/10.5336/medsci.2011-23682https://hdl.handle.net/11454/18102Ankylosing spondylitis (AS), the prototype of spondyloarthritis is a chronic inflammatory rheumatic disease with a prevalence of 0.5-1.9% among all types of spondyloarthritis. Inhibition of the proinflammatory cytokine tumour necrosis factor (TNF)-? has demonstrated efficacy in patients with active AS. However, de novo malignancies have been reported in some patients undergoing this therapy representing a major concern. Here, we reported a case with AS who was diagnosed with carcinoma of ovary after receiving therapy with infliximab. Copyright © 2013 by Türkiye Klinikleri.en10.5336/medsci.2011-23682info:eu-repo/semantics/openAccessAnkylosingInfliximabOvarian neoplasmsSpondylitisTumor necrosis factor alpha (36-68)Article331238240Q4